PLXP.Q Overzicht aandelen
PLx Pharma Winddown Corp. operates as a commercial-stage drug delivery platform technology company in the United States.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
PLx Pharma Winddown Corp. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$0.000001 |
| 52 Week Hoogtepunt | US$0.70 |
| 52 Week Laag | US$0.000001 |
| Bèta | 3.41 |
| 11 maand verandering | -99.50% |
| 3 maanden verandering | -99.98% |
| 1 Jaar Verandering | -100.00% |
| 33 jaar verandering | -100.00% |
| 5 jaar verandering | -100.00% |
| Verandering sinds IPO | -100.00% |
Recent nieuws en updates
Recent updates
PLx Pharma Non-GAAP EPS of -$0.52 misses by $0.02, revenue of $0.48M
Aug 12Is PLx Pharma (NASDAQ:PLXP) In A Good Position To Deliver On Growth Plans?
May 10
Most Shareholders Will Probably Find That The CEO Compensation For PLx Pharma Inc. (NASDAQ:PLXP) Is Reasonable
Nov 03We're Interested To See How PLx Pharma (NASDAQ:PLXP) Uses Its Cash Hoard To Grow
Sep 23PLx Pharma: First Commercial Launch Makes It Attractive
Sep 17PLx Pharma (NASDAQ:PLXP) Is In A Strong Position To Grow Its Business
Jun 15Have Insiders Been Buying PLx Pharma Inc. (NASDAQ:PLXP) Shares?
Mar 05PLx Pharma EPS misses by $0.10
Nov 16Rendement voor aandeelhouders
| PLXP.Q | US Pharmaceuticals | US Markt | |
|---|---|---|---|
| 7D | 0% | -3.7% | -1.6% |
| 1Y | -100.0% | 17.2% | 30.8% |
Rendement versus industrie: PLXP.Q underperformed the US Pharmaceuticals industry which returned -4.4% over the past year.
Rendement versus markt: PLXP.Q underperformed the US Market which returned 15.2% over the past year.
Prijsvolatiliteit
| PLXP.Q volatility | |
|---|---|
| PLXP.Q Average Weekly Movement | 54.0% |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stabiele aandelenkoers: PLXP.Q's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: PLXP.Q's weekly volatility (54%) has been stable over the past year, but is still higher than 75% of US stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2002 | 18 | Pat Lonergan | plxpharma.com |
PLx Pharma Winddown Corp. Samenvatting
| PLXP.Q fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$30.00 |
| Inkomsten(TTM) | -US$27.58m |
| Inkomsten(TTM) | US$4.54m |
0.0x
P/S-verhouding0.0x
Koers/WinstverhoudingIs PLXP.Q overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| PLXP.Q resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$4.54m |
| Kosten van inkomsten | US$4.34m |
| Brutowinst | US$203.00k |
| Overige uitgaven | US$27.78m |
| Inkomsten | -US$27.58m |
Laatst gerapporteerde inkomsten
Sep 30, 2022
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.90 |
| Brutomarge | 4.47% |
| Nettowinstmarge | -606.91% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde PLXP.Q op de lange termijn?
Bekijk historische prestaties en vergelijking